Chronic peripheral hyperinsulinemia induced by a variety of mechanisms fails to alter hypothalamic IGF-II receptor binding.
Lauterio
T J
TJ
Department of Internal Medicine, Eastern Virginia Medical School, Norfolk 23501.
Ahmed
I
I
Mullinax
K
K
D000818:Animals; D004041:Dietary Fats / Q000494:pharmacology; D005947:Glucose / Q000494:pharmacology; D006946:Hyperinsulinism / Q000139:chemically induced / Q000378:metabolism*; D007031:Hypothalamus / Q000187:drug effects / Q000378:metabolism*; D007262:Infusions, Intravenous; D007279:Injections, Subcutaneous; D007328:Insulin / Q000008:administration & dosage / Q000494:pharmacology; D007335:Insulin-Like Growth Factor II / Q000378:metabolism; D008297:Male; D009928:Organ Specificity; D051381:Rats; D017207:Rats, Sprague-Dawley; D017527:Receptor, IGF Type 2 / Q000187:drug effects / Q000378:metabolism*
D004041:Dietary Fats; D007328:Insulin; D017527:Receptor, IGF Type 2; D007335:Insulin-Like Growth Factor II; D005947:Glucose